Comparison of Urine Cell Characteristics by Flow Cytometry and Cytology in Patients Suspected of Having Bladder Cancer

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Clinical Chemistry and Laboratory Medicine

• Publication date

  2002-01-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1515/CCLM.2002.142PMID 12392312
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bladder wash flow cytometry in transitional cell carcinoma: useful or misleading?

  2004cited by this paper
• Diagnostic performance of the urinary bladder carcinoma antigen ELISA test and multiparametric DNA/cytokeratin flow cytometry in urine voided samples from patients with bladder carcinoma

  2001cited by this paper
• Clinical utility of flow cytometry in body fluid cytology: To flow or not to flow? That is the question

  2001cited by this paper
• Bladder cancer redefined

  1999cited by this paper
• The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder

  1998cited by this paper
• The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee.

  1998cited by this paper
• Reporting urinary bladder specimens containing bladder neoplasms.

  1997cited by this paper
• The value of DNA cytometry in transitional cell carcinoma of the urinary bladder.

  1997cited by this paper
• Quality control study by the French Cytometry Association on flow cytometric DNA content and S-phase fraction (S%). The Association Française de Cytométrie.

  1996cited by this paper
• Bladder cancer screening.

  1996cited by this paper
• The effect of number of histogram events on reproducibility and variation of flow cytometric proliferation measurement.

  1996cited by this paper
• Prognostic significance of DNA content in bladder cancer based on flow cytometric analysis of 249 transitional cell carcinomas.

  1995cited by this paper
• Fixation method useful for cytologic examination and DNA flow cytometry of exfoliated bladder cells.

  1993cited by this paper
• Consensus review of the clinical utility of DNA cytometry in bladder cancer. Report of the DNA Cytometry Consensus Conference.

  1993cited by this paper
• Failure of anticytokeratin 18 antibody to improve flow cytometric detection of bladder cancer

  1992cited by this paper
• Bladder cancer, 1992.

  1992cited by this paper
• Flow cytometry for detection and evaluation of urinary bladder carcinoma.

  1992cited by this paper
• Cellular DNA content and proliferative activity evaluated by flow cytometry versus histopathological and staging classifications in human bladder tumors.

  1991cited by this paper
• Is voided urine suitable for flow cytometric DNA analysis?

  1991cited by this paper
• DNA Ploidy and S Phase Fraction in Human Bladder Cancer

  1990cited by this paper
• Voided urine flow cytometry in screening high-risk patients for the presence of bladder cancer.

  1990cited by this paper
• Flow cytometry detection and evaluation of bladder tumors.

  1990cited by this paper
• A clinically applicable method to preserve urine and bladder washing cells for flow cytometric monitoring of bladder cancer patients.

  1990cited by this paper
• DNA ploidy and S phase fraction in human bladder cancer. Relation to survival and histological grade (WHO).

  1990cited by this paper
• Advances in screening protocols for the detection of early bladder cancer.

  1990cited by this paper
• Flow cytometry study of cytokeratin 18 expression according to tumor grade and deoxyribonucleic acid content in human bladder tumors.

  1989cited by this paper
• Cytology. Accuracy of diagnosis

  1989cited by this paper
• Flow cytometry deoxyribonucleic acid determinations and cytology of bladder washings: practical experience.

  1988cited by this paper
• Tissue‐specific markers in flow cytometry of urological cancers. III. Comparing chromosomal and flow cytometric dna analysis of bladder tumors

  1987cited by this paper
• The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma

  1987cited by this paper
• Flow Cytometric Identification of Human Bladder Cells Using a Cytokeratin Monoclonal Antibody a

  1986cited by this paper
• Cytology of bladder papilloma.

  1985cited by this paper
• Diagnostic value of cytology of voided urine.

  1985cited by this paper
• TISSUE‐SPECIFIC MARKERS IN FLOW CYTOMETRY OF UROLOGICAL CANCERS: CYTOKERATINS IN BLADDER CARCINOMA

  1985cited by this paper
• Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms

  1984cited by this paper
• Flow-cytometric analysis of mixed cell populations using intermediate filament antibodies.

  1984cited by this paper

• Urine cytological examination: an appropriate method that can be used to detect a wide range of urinary abnormalities

  2019cites this paper
• The biochemical value of urinary metalloproteinases 3 and 9 in diagnosis and prognosis of bladder cancer in Egypt

  2014cites this paper
• Utility of urine cytology in evaluating hematuria with sonographically suspected bladder lesion in patients older than 50 years

  2014cites this paper
• The Diagnostic Potential of Dielectric Properties, Telomerase Activity and Cytokeratin 20 in Urine Cells of Bladder Cancer Patients

  2012cites this paper
• Valoración de pruebas diagnósticas de laboratorio

  2012cites this paper
• Urine‐based Biomarkers

  2012cites this paper
• Urine cytology and adjunct markers for detection and surveillance of bladder cancer.

  2010cites this paper
• Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer.

  2010cites this paper
• Urothelial cancer biomarkers for detection and surveillance.

  2006cites this paper
• Telomerase activity, cytokeratin 20 and cytokeratin 19 in urine cells of bladder cancer patients.

  2006cites this paper
• Methodology in diagnostic laboratory test research in clinical chemistry and clinical chemistry and laboratory medicine.

  2004cites this paper